Skip to contentMAST ERLE T — Clovis Oncology, Inc. insider: 172 transactions · InsiderLensMAST ERLE T
- Director at Somaxon Pharmaceuticals, Inc. · on record since Jun 13, 2008
- Executive VP and CFO at Clovis Oncology, Inc. · on record since Nov 21, 2011
- Director at ZOGENIX, INC. · on record since Nov 22, 2010
- Chief Financial Officer at PHARMION CORP · on record since Nov 5, 2003
- Director at Receptos, Inc. · on record since Jul 19, 2013
- Director at Sienna Biopharmaceuticals, Inc. · on record since Jul 26, 2017
Insider trading activity of MAST ERLE T
- Transactions on record
- 172
- since Dec 4, 2003
- Open-market buys
- 17
- $258.8K
- Open-market sells
- 54
- $8.1M
- Companies traded
- 6
- last filing Mar 9, 2022
Figures computed from official regulatory filings — methodology.
Companies where MAST ERLE T has traded
- ZOGENIX, INC.41 tx · $812.2K · Mar 9, 2022
- Sienna Biopharmaceuticals, Inc.2 tx · $100.5K · Jun 4, 2018
- Clovis Oncology, Inc.56 tx · $5.5M · Nov 3, 2015
- Receptos, Inc.9 tx · $5.9M · Aug 27, 2015
- Somaxon Pharmaceuticals, Inc.29 tx · $110.2K · Mar 8, 2013
- PHARMION CORP35 tx · $2.8M · Mar 12, 2008
Track record of MAST ERLE T
Statistical track record
Free- Open-market buys
- 17
- Last buy
- Aug 1, 2017
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of MAST ERLE T
Co-insiders of MAST ERLE T
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Allen Andrew RClovis Oncology, Inc. +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Mar 9, 2022 | OtherD | -6,250 | — | — | SEC |
| Mar 9, 2022 | OtherD | -9,000 | — | — | SEC |
| Mar 9, 2022 | OtherD | -20,000 | — | — | SEC |
| Mar 9, 2022 | OtherD | -22,000 | — | — | SEC |
| Mar 9, 2022 | OtherD | -20,000 | — | — | SEC |
| Mar 9, 2022 | Other | -3,027 | — | — | SEC |
| Feb 3, 2022 | ExerciseD | -1,250 | 0.00 USD | $0 | SEC |
| Feb 3, 2022 | Sell | -1,250 | 26.04 USD | $32.6K | SEC |
| Feb 3, 2022 | Exercise | 1,250 | 12.00 USD | $15K | SEC |
| Jan 21, 2022 | Exercise | 4,375 | 14.88 USD | $65.1K | SEC |
| Jan 21, 2022 | ExerciseD | -6,250 | 0.00 USD | $0 | SEC |
| Jan 21, 2022 | Exercise | 6,250 | 15.04 USD | $94K | SEC |
| Jan 21, 2022 | ExerciseD | -4,375 | 0.00 USD | $0 | SEC |
| Jan 21, 2022 | Sell | -15,000 | 26.09 USD | $391.4K | SEC |
| Jan 21, 2022 | Exercise | 4,375 | 12.00 USD | $52.5K | SEC |
| Jan 21, 2022 | ExerciseD | -4,375 | 0.00 USD | $0 | SEC |
| May 28, 2021 | AwardD | 22,000 | 0.00 USD | $0 | SEC |
| Jun 29, 2020 | AwardD | 13,000 | 0.00 USD | $0 | SEC |
| May 28, 2019 | AwardD | 13,000 | 0.00 USD | $0 | SEC |
| Nov 26, 2018 | Sell | -1,468 | 42.08 USD | $61.8K | SEC |
| Oct 4, 2018 | ExerciseD | -1,250 | 0.00 USD | $0 | SEC |
| Oct 4, 2018 | ExerciseD | -218 | 0.00 USD | $0 | SEC |
| Oct 4, 2018 | Exercise | 1,250 | 28.00 USD | $35K | SEC |
| Oct 4, 2018 | Exercise | 218 | 20.00 USD | $4.4K | SEC |
| Jun 4, 2018 | AwardD | 10,000 | 0.00 USD | $0 | SEC |